Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme

• 收藏
• 分享

专利权人:

AbbVie Inc.

发明人:

Sorensen, Bryan K.,Yong, Hong,Link, James T.,Rohde, Jeffrey J.,Yeh, Vince S.,Patel, Jyoti R.,Winn, Martin,Shuai, Qi,Dinges, Jurgen

申请号：

AU2013206051

公开号：

AU2013206051A8

申请日:

2013.05.28

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2013206051A820160218.pdf#####ADAMANTYL DERIVATIVES AS INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME Abstract The present invention relates to compounds which are inhibitors of the 1 1-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome and other diseases and conditions that are mediated by excessive glucocorticoid action.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/